A critical review of non invasive procedures for the evaluation of body iron burden in thalassemia major patients

Pediatric Endocrinology Reviews

Volumn 6, Issue SUPPL. 1, 2008, Pages 193-203

  Maggio, Aurelio ^a   Capra, Marcello ^b   Pepe, Alessia ^c   Mancuso, Luigi ^d   Cracolici, Eliana ^e   Vitabile, Salvatore ^e   Rigano, Paolo ^a   Cassarà, Filippo ^a   Midiri, Massimo ^e  

^a VILLA SOFIA CERVELLO HOSPITAL   (Italy)

^b AO G Di Cristina   (Italy)

^c FONDAZIONE TOSCANA GABRIELE MONASTERIO   (Italy)

^d AO V Cervello   (Italy)

^e UNIVERSITY OF PALERMO   (Italy)

Author keywords

Evaluation chelation treatment; Iron burden; Non invasive procedures; Thalassemia major management

Indexed keywords

DEFERIPRONE; DEFEROXAMINE; FERRIOXAMINE; GADOLINIUM; IRON; IRON CHELATING AGENT;

ADRENAL DISEASE; BETA THALASSEMIA; BLOOD TRANSFUSION; BONE MARROW DISEASE; BRAIN DISEASE; CARDIOMYOPATHY; CLINICAL RESEARCH; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; DOPPLER FLOWMETRY; DRUG EFFICACY; DRUG MONITORING; DRUG SAFETY; EARLY DIAGNOSIS; ELECTRON SPIN RESONANCE; FOLLOW UP; FUNCTIONAL ASSESSMENT; GATED IMAGING; GROWTH HORMONE DEFICIENCY; HEART FAILURE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE EJECTION FRACTION; HEMOCHROMATOSIS; HISTOPATHOLOGY; HUMAN; HYPOGONADISM; HYPOGONADOTROPIC HYPOGONADISM; HYPOPHYSIS DISEASE; IMAGE DISPLAY; IMAGE PROCESSING; IMAGE QUALITY; INTERMETHOD COMPARISON; IRON OVERLOAD; LABORATORY TEST; LIVER BIOPSY; LIVER DISEASE; LYMPHADENOPATHY; MONOTHERAPY; NON INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PANCREAS DISEASE; PATIENT MONITORING; PATIENT SAFETY; PREDICTION; REPRODUCIBILITY; REVIEW; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SPLEEN DISEASE;

BETA-THALASSEMIA; ECHOCARDIOGRAPHY; HUMANS; IRON; IRON OVERLOAD; MAGNETIC RESONANCE IMAGING;

EID: 58249121136     PISSN: 15654753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (103)

1. Borgna-Pignatti C, Rugolotto S, De Stefano P, Zhao H, Cappellini MD, Del Vecchio GC, Romeo MA, Forni GL, Gamberini MR, Ghilardi R, Piga A, Cnaan A. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica 2004;89:1187-1193
2. Lucarelli G, Andreani M, Angelucci E. The Cure of the Thalassemia with Bone Marrow Transplantation. Bone Marrow Transplantation 2001;28(Suppl 1):S11-S13
3. Lucarelli G, Clift RA, Galimberti M, Angelucci E, Giardini C, Baronciani D, Polchi P, Andreani M, Gaziev D, Erer B, Ciaroni A, D'Adamo F, Alberini F, Muretto P. Bone marrow transplantation in adult thalassemic patients. Blood 1999;15;93(4):1164-1167
4. Guidelines for the Clinical Management of Thalassaemia 2nd Edition. Thalassaemia International Federation, December 2007
5. Angelopoulos NG, Zervas A, Livadas S, Adamopoulos I, Giannopoulos D, Goula A, Tolis G. Reduced insulin secretion in normoglycaemic patients with beta-thalassemia major. Diabet Med 2006;23(12):1327-1331
6. Di Marco V, Craxi A Liver complications in patients affected by thalassemia. Clinical aspects and therapy of thalassemia. SEE, Firenze, Italy, 2004
7. Prati D, Maggioni M, Milani S, Cerino M, Cianciulli P, Coggi G, Forni GL, Magnano C, Meo A, Gramignoli R, Rebulla P, Fiorelli G, Cappellini MD; Cooleycare Cooperative Group. Clinical and histological characterization of liver disease in patients with transfusion-dependent beta-thalassemia. A multicenter study of 117 cases. Haematologica 2004;89(10):1179-1186
8. Telfer PT, Garson JA, Whitby K, Grant PR, Yardumian A, Hoffbrand AV, Wonke B. Combination therapy with interferon alpha and ribavirin for chronic hepatitis C virus infection in thalassaemic patients. Br J Haematol 1997;98(4):850-855
9. Mancuso A, Sciarrino E, Renda MC, Maggio A. A prospective study of hepatocellular carcinoma incidence in thalassemia. Hemoglobin 2006;30(1):119-124
10. Gandon Y, Olivié D, Guyader D, Aubé C, Oberti F, Sebille V, Deugnier Y. Non-invasive assessment of hepatic iron stores by MRI. Lancet 2004;363:357-362
11. Kaltwasser JP, Gottschalk R, Schalk KP, Hartl W. Non-invasive quantitation of liver iron-overload by magnetic resonance imaging. Br J Haematol 1990;74:360-363
12. Chezmar JL, Nelson RC, Malko JA, Bernardino ME. Hepatic iron overload: diagnosis and quantification by noninvasive imaging. Gastrointest Radiol 1990;15:27-31
13. Bonkovsky HL, Slaker DP, Bills EB, Wolf DC. Usefulness and limitations of laboratory and hepatic imaging studies in iron-storage disease. Gastroenterology 1990;99:1079-1091
14. Guyader D, Gandon Y, Robert JY, Heautot JF, Jouanolle H, Jacquelinet C, Messner M, Deugnier Y, Brissot P. Magnetic resonance imaging and assessment of liver iron content in genetic hemochromatosis. J Hepatol 1992;15:304-308
15. Gandon Y, Guyader D, Heautot JF, Reda MI, Yaouanq J, Buhé T, Brissot P, Carsin M, Deugnier Y. Hemochromatosis: diagnosis and quantification of liver iron with gradient-echo MR imaging. Radiology 1994;193:533-538
16. Argyropoulou MI, Kiortsis DN, Efremidis SC MRI of the liver and the pituitary gland in patients with beta-thalassemia major: does hepatic siderosis predict pituitary iron deposition? Eur Radiol 2003;13:12-16
17. Drakonaki EE, Maris TG, Papadakis A, Karantanas AH. Bone marrow changes in beta-thalassemia major: quantitative MR imaging findings and correlation with iron stores. Eur Radiol 2007;17:2079-2087
18. Papakonstantinou O, Maris TG, Kostaridou S, Ladis V, Vasiliadou A, Gourtsoyiannis NC. Abdominal lymphadenopathy in beta-thalassemia: MRI features and correlation with liver iron overload and posttransfusion chronic hepatitis C. AJR 2005;185:219-224
19. Papakonstantinou O, Ladis V, Kostaridou S, Maris T, Berdousi H, Kattamis C, Gourtsoyiannis N. The pancreas in beta-thalassemia major: MR imaging features and correlation with iron stores and glucose disturbances. Eur Radiol 2007;17(6):1535-1543
20. Papakonstantinou O, Drakonaki EE, Maris T, Vasiliadou A, Papadakis A, Gourtsoyiannis N. MR imaging of spleen in beta-thalassemia major. Abdom Imaging 2006;DOI 10.1007/s00261-006-9138-9134
21. Rocchi E, Cassanelli M, Borghi A, Paolillo F Pradelli M, Casalgrandi G, Burani A, Gallo E. Magnetic resonance imaging and different levels of iron overload in chronic liver disease. Hepatology 1993;17:997-1002
22. Gomori JM, Horev G, Tamary H, Zandback J, Kornreich L, Zaizov R, Freud E, Krief O, Ben-Meir J, Rotem H. Hepatic iron overload: quantitative MR imaging. Radiology 1991;179:367-369
23. Gelman N, Gorell JM, Barker PB, Savage RM, Spickler EM, Windham JP, Knight RA. MR imaging of human brain at 3.0 T: preliminary report on transverse relaxation rates and relation to estimated iron content. Radiology 1999;210:759-767
24. Ghugre NR, Enriquez CM, Coates TD, Nelson MD Jr, Wood JC. Improved R2* measurements in myocardial iron overload. J Magn Reson Imaging 2006;23:9-16
25. Mavrogeni SI, Markussis V, Kaklamanis L, Tsiapras D, Paraskevaidis I, Karavolias G, Karagiorga M, Douskou M, Cokkinos DV, Kremastinos DT. A comparison of magnetic resonance imaging and cardiac biopsy in the evaluation of heart iron overload in patients with beta-thalassemia major. Eur J Haematol 2005;75:241-247
26. Aessopos A, Giakoumis A, Fragodimitri C, Karabatsos F, Hatziliami A, Yousef J, Gotsis E, Berdoukas V, Karagiorga M. Correlation of echocardiography parameters with cardiac magnetic resonance imaging in transfusion-dependent thalassaemia major. Eur J Haematol 2007;78:58-65
27. Alexopoulou E, Stripeli F, Baras P, Seimenis I, Kattamis A, Ladis V, Efstathopoulos E, Brountzos EN, Kelekis AD, Kelekis NL. R2 relaxometry with MRI for the quantification of tissue iron overload in beta-thalassemic patients. J Magn Reson Imaging 2006;23:163-170
28. Voskaridou E, Douskou M, Terpos E, Papassotiriou I, Stamoulakatou A, Ourailidis A, Loutradi A, Loukopoulos D. Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease. Br J Haematol 2004;126:736-742
29. Carneiro AA, Fernandes JP, de Araujo DB, Elias J Jr, Martinelli AL, Covas DT, Zago MA, Angulo IL, St Pierre TG, Baffa O. Liver iron concentration evaluated by two magnetic methods: magnetic resonance imaging and magnetic susceptometry. Magn Reson Med 2005;54:122-128
30. Pepe A, Positano V, Santarelli MF, Sorrentino F, Cracolici E, De Marchi D, Maggio A, Midiri M, Landini L, Lombardi M. Multislice multiecho T2 cardiovascular magnetic resonance for detection of the heterogeneous distribution of myocardial iron overload. J Magn Reson Imaging 2006;23:662-668
31. Argyropoulou MI, Metafratzi Z, Kiortsis DN, Bitsis S, Tsatsoulis A, Efremidis S. T2 relaxation rate as an index of pituitary iron overload in patients with beta-thalassemia major. AJR 2000;175:1567-1569
32. St Pierre TG, Clark PR, Chua-Anusorn W. Measurement and mapping of liver iron concentrations using magnetic resonance imaging. Ann N Y Acad Sci 2005;1054:379-385
33. Ernst O, Sergent G, Bonvarlet P, Canva-Delcambre V, Paris JC, L'Herminé C. Hepatic iron overload: diagnosis and quantification with MR imaging. AJR 1997;168:1205-1208
34. Carr HY, Purcell EM. Effects of diffusion on free precession in nuclear magnetic resonance experiments. Phys Rev 1954;94:630-638
35. Meiboom S, Gill D. Modified spin-echo method for measuring nuclear relaxation times. Rev Sci Instrum 1958;29:688-691
36. In den Kleef JJ, Cuppen JJ. RLSQ: T1, T2, and rho calculations, combining ratios and least squares. Magn Reson Med 1987;5:513-524
37. St Pierre TG, Clark PR, Chua-anusorn W, Fleming AJ, Jeffrey GP, Olynyk JK, Pootrakul P, Robins E, Lindeman R. Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood 2005;105:855-861
38. Anderson LJ, Holden S, Davis B, Prescott E, Charrier CC, Bunce NH, Firmin DN, Wonke B, Porter J, Walker JM, Pennell DJ. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 2001;22:2171-2179
39. Wood JC, Tyszka JM, Carson S, Nelson MD, Coates TO. Myocardial iron loading in transfusion-dependent thalassemia and sickle cell disease. Blood 2004;103:1934-1936
40. Jensen PD, Jensen FT, Christensen T, Eiskjaer H, Baandrup U, Nielsen JL. Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with deferrioxamine: indication of close relation between myocardial iron content and chelatable iron pool. Blood 2003;101:4632-4639
41. Westwood MA, Anderson LJ, Firmin DN, Gatehouse PD, Lorenz CH, Wonke B, Pennell DJ. Interscanner reproducibility of cardiovascular magnetic resonance T2* measurements of tissue iron in thalassemia. J Magn Reson Imaging 2003;18:616-620
42. Gorell JM, Ordidge RJ, Brown GG, Deniau JC, Buderer NM, Helpern JA. Increased iron-related MRI contrast in the substantia nigra in Parkinson's disease. Neurology 1995;45:1138-1143
43. Ordidge RJ, Gorell JM, Deniau JC, Knight RA, Helpern JA. Assessment of relative brain iron concentrations using T2-weighted and T2*-weighted MRI at 3 Tesla. Magn Reson Med 1994;32:335-341
44. Papakonstantinou OG, Maris TG, Kostaridou V, Gouliamos AD, Koutoulas GK, Kalovidouris AE, Papavassiliou GB, Kordas G, Kattamis C, Vlahos LJ. Assessment of liver iron overload by T2-quantitative magnetic resonance imaging: correlation of T2-QMRI measurements with serum ferritin concentration and histologic grading of siderosis. Magn Reson Imaging 1995;13:967-977
45. Christoforidis A, Haritandi A, Tsitouridis I, Tsatra I, Tsantali H, Karyda S, Dimitriadis AS, Athanassiou-Metaxa M. Correlative study of iron accumulation in liver, myocardium, and pituitary assessed with MRI in young thalassemic patients. J Pediatr Hematol Oncol 2006;28:311-315
46. Wood JC, Enriquez C, Ghugre N, Tyzka JM, Carson S, Nelson MD, Coates TD. MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood 2005;106:1460-1465
47. Papakonstantinou O, Kostaridou S, Maris T, Gouliamos A, Premetis E, Kouloulias V, Nakopoulou L, Kattamis C. Quantification of liver iron overload by T2 quantitative magnetic resonance imaging in thalassemia: impact of chronic hepatitis C on measurements. J Pediatr Hematol Oncol 1999;21:142-148
48. Aldouri MA, Wonke B, Hoffbrand AV, Flynn DM, Laulicht M, Fenton LA, Scheuer PJ, Kibbler CC, Allwood CA, Brown D. iron state and hepatic disease in patients with thalassaemia major, treated with long term subcutaneous desferrioxamine. J Clin Pathol 1987;40:1353-1359
49. Christoforidis A, Haritandi A, Tsitouridis I, Tsatra I, Tsantali H, Karyda S, Dimitriadis AS, Athanassiou-Metaxa M. Correlative study of iron accumulation in liver, myocardium, and pituitary assessed with MRI in young thalassemic patients. J Pediatr Hematol Oncol 2006;28:311-315
50. St Pierre TG, Tran KC, Webb J, Macey DJ, Heywood BR, Sparks NH, Wade VJ, Mann S, Pootrakul P. Organ-specific crystalline structures of ferritin cores in beta-thalassemia/hemoglobin E. Biol Met 1991;4:162-165
51. Kushner JP, Porter JP, Olivieri NF. Secondary iron overload. Hematology Am Soc Hematol Educ Program 20;47-61
52. Gatter KC, Brown G, Trowbridge IS, Woolston RE, Mason DY. Transferrin receptors in human tissues: their distribution and possible clinical relevance. J Clin Pathol 1983;36:539-545
53. Atkin SL, Burnett HE, Green VL, White MC, Lombard M. Expression of the transferrin receptor in human anterior pituitary adenomas is confined to gonadotrophinomas. Clin Endocrinol (Oxf) 1996;44:467-471
54. Thorstensen K, Trinder D, Zak O, Aisen P. Uptake of iron from N-terminal half-transferrin by isolated rat hepatocytes. Evidence of transferrin-receptor-independent iron uptake. Eur J Biochem 1995;232:129-133
55. Positano V, Salani B, Scattini B, Santarelli MF, Ramazzotti A, Pepe A, Lombardi M, Landini L. A robust method for assessment of iron overload in liver by magnetic resonance imaging. Conf Proc IEEE Eng Med Biol Soc 2007;2895-2898
56. Anderson LJ, Westwood MA, Holden S, Davis B, Prescott E, Wonke B, Porter JB, Walker JM, Pennell DJ. Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance. Br J Haematol 2004;127:348-355
57. Wood JC, Tyszka JM, Carson S, Nelson MD, Coates TD. Myocardial iron loading in transfusion-dependent thalassemia and sickle cell disease. Blood 2004;103:1934-1936
58. Pepe A, Lombardi M, Positano V, Cracolici E, Capra M, Malizia R, Prossomariti L, De Marchi D, Midiri M, Maggio A. Evaluation of the efficacy of oral deferiprone in β-thalassemia major by multislice multiecho T2*. Eur J Haematol 2006;(76):183-192
59. Galia M, Midiri M, Bartolotta V, Morabito A, Rizzo M, Mangiagli A, Malizia R, Borsellino Z, Capra M, D'Ascola DG, Magnano C, Gerardi C, Rigano P, Maggio A. Potential myocardial iron content evaluation by magnetic resonance imaging in thalassemia major patients treated with Deferoxamine or Deferiprone during a randomized multicenter prospective clinical study. Hemoglobin 2003;27(2):63-76
60. Mavrogeni SI, Markussis V, Kaklamanis L, Tsiapras D, Paraskevaidis I, Karavolias G, Karagiorga M, Douskou M, Cokkinos DV, Kremastinos DT. A comparison of magnetic resonance imaging and cardiac biopsy in the evaluation of heart iron overload in patients with beta-thalassemia major. Eur J Haematol 2005;75(3):241-247
61. He T, Gatehouse PD, Anderson LJ, Tanner M, Keegan J, Pennell DJ, Firmin DN. Development of a novel optimized breathhold technique for myocardial T2 measurement in thalassemia. J Magn Reson Imaging 2006;24:580-585
62. Westwood M, Anderson LJ, Firmin DN, Gatehouse PD, Charrier CC, Wonke B, Pennel DJ. A single breath-hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial overload. J Magn Reson Imaging 2003;18:33-39
63. Positano V, Pepe A, Santarelli MF, Scattini B, De Marchi D, Ramazzotti A, Forni G, Borgna-Pignatti C, Lai ME, Midiri M, Maggio A, Lombardi M, Landini L Standardized T2* map of normal human heart in vivo to correct T2* segmental artefacts. NMR in Biomedicine 2007;20:578-590
64. Tanner MA, He T, Westwood MA, Firmin DN, Pennell DJ. Multi-center validation of the transferability of the magnetic resonance T2* technique for the quantification of tissue iron. Haematologica 2006;91:1388-1391
65. Wood JC, Otto-Duessel M, Aguilar M, Nick H, Nelson MD, Coates TD, Pollack H, Moats R. Cardiac iron determines cardiac T2*, T2, and T1 in the gerbil model of iron cardiomyopathy. Circulation 2005 26; 112:535-543
66. Tanner M, Porter J, Westwood M, Nair S, Anderson L, Walker J, Pennell D. Myocardial T2* in patients with cardiac failure secondary to iron overload. Blood 2005;106:Abstract.
67. Sironi M, Lombardi M, Pepe A, De Marchi D. Study of heart function. In: Lombardi M, Bartolozzi C, eds. MRI of Heart and Vessels. Italia: Springer-Verlag 2005
68. Pepe A, Cracolici E, Santarelli MF, Santarelli G, DeMarchi AD, Deiana M, Filosa A, Di Salvo V, Borsellino Z, Pitrolo L, Midiri M, Lombardi M. Cardiac Magnetic Resonance characterization of Thalassemia Intermedia patients confronted with Thalassemia Major patients. J Am Coll Cardiol 2006;47:136A
69. Cogliandro T, Derchi G, Mancuso L, Mayer MC, Pannone B, Pepe A, Pili M, Bina P, Cianciulli P, De Sanctis V, Maggio A. Guideline recommendations for heart complications in thalassemia major. Journal of Cardiovascular Medicine 2008;9(5):515-525
70. Bergeron C, Kovacs K. Pituitary siderosis. A histologic, immunocytologic and ultrastructural study. Am J Pathol 1978;93:295-309
71. Oerter KE, Kamp GA, Munson PJ, Nienhuis AW, Cassorla FG, Manasco PK. Multiple hormone deficiencies in children with hemochromatosis. J Clin Endocrinol Metab 1993;76:357-361
72. Argyropoulou MI, Kiortsis DN, Metafratzi Z, Bitsis S, Tsatoulis A, Efremidis SC. Pituitary gland height evaluated by MR in patients with beta-thalassemia major: a marker of pituitary gland function. Neuroradiology 2001;43:1056-1058
73. Sparacia G, Banco A, Midiri M, Iaia A. MR imaging technique for the diagnosis of pituitary iron overload in patients with transfusion-dependent beta-thalassemia major. AJNR Am J Neuroradiol. 1998;19(10):1905-1907
74. Sparacia G, Midiri M, D'Angelo P, Lagalla R. Magnetic resonance imaging of the pituitary gland in patients with secondary hypogonadism due to transfusional hemochromatosis. MAGMA 1999;8(2):87-90
75. Argyropoulou MI, Metafratzi Z, Kiortsis DN, Bitsis S, Tsatsoulis A, Efremidis S. T2 relaxation rate as an index of pituitary iron overload in patients with beta-thalassemia major. AJR Am J Roentgenol 2000;175(6):1567-1569
76. Christoforidis A, Haritandi A, Perifanis V, Tsatra I, Athanassiou-Metaxa M, Dimitriadis AS. MRI for the determination of pituitary iron overload in children and young adults with beta-thalassaemia major. Eur J Radiol. 2007;62(1):138-142 Epub 2006 Dec 11
77. Au WY, Lam WW, Chu W, Tam S, Wong WK, Liang R, Ha SY. A T2* magnetic resonance imaging study of pancreatic iron overload in thalassemia major. Haematologica 2008;93(1):116-119
78. Christoforidis A, Haritandi A, Perifanis V, Tsatra I, Athanassiou-Metaxa M, Dimitriadis AS MRI for the determination of pituitary iron overload in children and young adults with beta-thalassaemia major. Eur J Radiol. 2007;62:138-142
79. Argyropoulou MI, Kiortsis DN, Astrakas L, Metafratzi Z, Chalissos N, Efremidis SC. Liver, bone marrow, pancreas and pituitary gland iron overload in young and adult thalassemic patients: a T2 relaxometry study. Eur Radiol 2007;DOI 10.1007/s00330-007-0683-1
80. Metafratzi Z, Argyropoulou MI, Kiortsis DN, Tsampoulas C, Chaliassos N, Efremidis SC T(2) relaxation rate of basal ganglia and cortex in patients with beta-thalassaemia major. Br J Radiol 2001;74:407-410
81. Kattamis C, Ladis V, Tsoussis D, Kaloumenou I, Theodoridis C. Evolution of glucose intolerance and diabetes in transfused patients with thalassemia. Pediatr Endocrinol Rev 2 2004;267-271
82. Gullo L, Corcioni E, Brancati C, Bria M, Pezzilli R, Sprovieri G. Morphologic and functional evaluation of the exocrine pancreas in beta-thalassemia major. Pancreas 1993;8:176-180
83. Midiri M, Lo Casto A, Sparacia G, D'Angelo P, Malizia R, Finazzo M, Montalto G, Solbiati L, Lagalla R, De Maria M. MR imaging of pancreatic changes in patients with transfusion-dependent beta-thalassemia major 1999;AJR173:187-192
84. Drakonaki E, Papakonstantinou O, Maris T, Vasiliadou A, Papadakis A, Gourtsoyiannis N. Adrenal glands in beta-thalassemia major: magnetic resonance (MR) imaging features and correlation with iron stores. Eur Radiol 2005;15:2462-2468
85. Rund D, Rachmilewitz E. Beta-thalassemia. N Engl J Med 2005;353:1135-1146
86. Gabutti V, Piga A, Sacchetti L, Sandri A, Biginelli M, Saracco P, Ferri M. Quality of life and life expectancy in thalassemic patients with complications. Prog Clin Biol Res 1989;309:35-41
87. Martins R, Picanço I, Fonseca A, Ferreira L, Rodrigues O, Coelho M, Seixas T, Miranda A, Nunes B, Costa L, Romão L, Faustino P. The role of HFE mutations on iron metabolism in beta-thalassemia carriers. J Hum Genet 2004;49:651-655
88. Katz DS. Splenic extramedullary hematopoiesis: large focal lesion in a patient with thalassemia. AJR 1999;173:1715-1716
89. Nielsen P, Kordes U, Fischer R, Engelhardt R, Janka GE. SQUID-biosusceptometry in iron overloaded patients with hematologic diseases Klin Padiatr 2002;214(4):218-22
90. Fischer R, Piga A, Harmatz P, Nielsen P. Monitoring long-term efficacy of iron chelation treatment with biomagnetic liver susceptometry. Ann N Y Acad Sci 2005;1054:350-357
91. Fung EB, Fischer R, Pakbaz Z, Fagaly RL, Vichinsky E, Starr TN, Ewing T, Paulson DN, Hassenzahl WV, Harmatz P. The new SQUID biosusceptometer at Oakland: first year of experience. Neurol Clin Neurophysiol. 2004;30:5
92. Ropert-Bouchet M, Turin B, Graham G, Rabault B, Le Treut A, Brissot P, Loreal O, Alberti D and Deugnier Y Drying methods affect the wet:dry weight ratio of liver tissue samples and impact liver iron content (LIC) measurements. P274, Bio Iron 2005;22-26, Prague
93. Cappellini MD, Cohen A, Piga A, Bejaoui M, Perrotta S, Agaoglu L, Aydinok Y, Kattamis A, Kilinc Y, Porter J, Capra M, Galanello R, Fattoum S, Drelichman G, Magnano C, Verissimo M, Athanassiou-Metaxa M, Giardina P, Kourakli-Symeonidis A, Janka-Schaub G, Coates T, Vermylen C, Olivieri N, Thuret I, Opitz H, Ressayre-Djaffer C, Marks P, Alberti D. A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassaemia. Blood 2006;107(9):3455-3462
94. Cogliandro T, Derchi G, Mancuso L, Mayer MC, Pannone B, Pepe A, Pili M, Bina P, Cianciulli P, De Sanctis V, Maggio A: Recommendations for the heart complications in Thalassemia Major. J Cardiovasc Med 2008;9(5):515-525
95. Aessopos A, Deftereos S, Tsironi M, Karabatsos F, Yousef J, Fragodimitri C, Hatziliani A, Karagiorga M. Predictive echo-Doppler indices of left ventricular impairment in B-thalassemic patients. Ann Hematol 2007;86:429-434
96. Davis BA, O'Sullivan C, Jarrit PH, Porter JB. Value of sequential monitoring of left ventricular ejection fraction in the management of thalassemia major. Blood 2004;104:263-269
97. Kremastinos DT, Tsiapras DP, Tsetsos GA, Rentoukas EI, Vretou HP, Toutouzas PK: Left ventricular diastolic Doppler characteristics in B Thalassemia Major. Circulation 1995;91:66-70
98. Hahalis G, Manolis AS, Apostolopoulos D, Alexopoulos D, Vagenakis AG, Zoumbos NC. Right ventricular cardiomyopathy in B- Thalassemia major. Eur Heart J 2002;23:147-151
99. Colle IO, Moreau R, Godinho E, Belghiti J, Ettori F, Cohen-Solal A, Mal H, Bernuau J, Marty J, Lebrec D, Valla D, Durand F. Diagnosis of porto-pulmonary hypertension in candidates for liver transplantation: a prospective study. Hepatology 2003;37:401-409
100. Efthimiadis GK, Giannakoulas G, Hassapopoulou HP, Karvounis HI, Tsikaderis DD, Styliadis IH, Parcharidis GE. Prognostic significance of right ventricular diastolic function in thalassemia major. Swiss Med WKLY 2008;138:52-54
101. Giakoumis A, Berdoukas V, Gotsis E, Aessopos A. Comparison of echocardiographic (US) volumetry with cardiac magnetic resonance (CMR) imaging in transfusion dependent thalassemia major (TM). Cardiovasc Ultrasound 2007:DOI:101186/1476-7120-5-24
102. Westwood MA, Wonke B, Maceira AM, Prescott E, Walker JM, Porter JB, Pennell DJ. Left ventricular diastolic function compared with T2* cardiovascular magnetic resonance for early detection of myocardial iron overload in thalassemia major. J Magn Reson Imaging 2005;22:229-233
103. Maggio A. Light and shadows in the iron chelation treatment of haematological diseases. Br. J. Of Haematol 2007;138:407-421